Treatment of Machado-Joseph disease with trimethoprim-sulphamethoxazole following successful desensitisation.
Ablin
Jacob
J
Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. ajacob@post.tau.ac.il
Elgan
Nino
N
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D017827:Machado-Joseph Disease / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination